PE/Cyanine7 anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PEslashCy7_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (top) or PE/Cyanine7 Armenian hamster IgG isotype control (bottom)
  • N418_A_PEslashCy7_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (top) or PE/Cyanine7 Armenian hamster IgG isotype control (bottom)
  • N418_B_PEslashCy7_Neg_071006
See PE/Cyanine7 spectral data
Cat # Size Price Quantity Avail. Save
117317 25 µg 68€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117318 100 µg 168€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, and immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.



BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
Product Citations
  1. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  2. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  3. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  4. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  5. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  6. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  7. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  8. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  9. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  10. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  11. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  12. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  13. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  14. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  15. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  16. Thwe PM et al. 2017. Cell metabolism. 26(3):558-567 . PubMed
  17. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  18. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  19. Zwick M, et al. 2019. Front Immunol. 10:222. PubMed
  20. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  21. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  22. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  23. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  24. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  25. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  26. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  27. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  28. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  29. Christ A, et al. 2018. Cell. 172:162. PubMed
  30. Kelsey E Sivick et al. 2018. Cell reports. 25(11):3074-3085 . PubMed
  31. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  32. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  33. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  34. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  35. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  36. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  37. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  38. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  39. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  40. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  41. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  42. Schuh E, et al. 2017. J Immunol. 198:3081. PubMed
  43. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  44. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  45. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  46. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  47. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  48. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  49. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  50. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  51. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  52. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  53. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  54. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  55. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  56. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  57. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  58. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
  59. Kim M, et al. 2018. Immunity. 49:151. PubMed
  60. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  61. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  62. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  63. Baudoux T, et al. 2018. Sci Rep. 4.0375. PubMed
  64. Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed
  65. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  66. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  67. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  68. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  69. Al–Rashed F, et al. 2020. Sci Rep. 10:16802. PubMed
  70. Hennion-Tscheltzoff O, et al. 2013. Blood. 121:4684. PubMed
  71. Škrnjug I, et al. 2014. PLoS One. 9:95728. PubMed
  72. Suzuki T, et al. 2014. J Dermatol Sci. 74:116. PubMed
  73. Morgado P, et al. 2014. Infect Immun . 82:4047. PubMed
  74. Škrnjug I, et al. 2014. PLoS One. 9:110150. PubMed
  75. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  76. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  77. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  78. Stack G, et al. 2015. PLoS Pathog. 11:1004641. PubMed
  79. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  80. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  81. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  82. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  83. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  84. Colliou N, et al. 2015. Toxins. 7: 3805 - 3817. PubMed
  85. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  86. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  87. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  88. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  89. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  90. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  91. Velázquez F, et al. 2016. J Immunol. 196: 1305 - 1316. PubMed
  92. Rosen D, et al. 2016. J Infect Dis. 213: 649 - 658. PubMed
  93. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  94. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
  95. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  96. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  97. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  98. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  99. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  100. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  101. Ghosh D, et al. 2016. J Immunol. 197: 1788 - 1800. PubMed
  102. Shepardson K, et al. 2016. MBio. 7: e00506-16. PubMed
  103. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  104. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  105. Kolawole A, et al. 2015. J Virol. 90: 1499-1506. PubMed
  106. Yasuda T, et al. 2016. PLoS One. 11:e0167952. PubMed
  107. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  108. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
RRID
AB_493569 (BioLegend Cat. No. 117317)
AB_493568 (BioLegend Cat. No. 117318)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account